[HTML][HTML] Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study

N Nagata, S Nishijima, Y Kojima, Y Hisada, K Imbe… - Gastroenterology, 2022 - Elsevier
Background & Aims To identify gut and oral metagenomic signatures that accurately predict
pancreatic ductal carcinoma (PDAC) and to validate these signatures in independent …

[HTML][HTML] Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer

J Yang, Y Ma, Q Tan, B Zhou, D Yu, M Jin… - Frontiers in …, 2023 - frontiersin.org
Background Gut microbiome plays an indispensable role in the occurrence and progression
in various diseases. The incidence of pancreatic cancer (PC) and liver metastasis (PCLM) …

[HTML][HTML] The gut microbiome and hepatocellular carcinoma: implications for early diagnostic biomarkers and novel therapies

Y Kang, Y Cai, Y Yang - Liver Cancer, 2022 - karger.com
Hepatocellular carcinoma (HCC) ranks the third place among all causes inducing cancer-
associated mortality, worldwide. HCC nearly exclusively occurs in cases suffering from …

Microbiota, oral microbiome, and pancreatic cancer

DS Michaud, J Izard - The Cancer Journal, 2014 - journals.lww.com
Only 30% of patients with a diagnosis of pancreatic cancer survive 1 year after the
diagnosis. Progress in understanding the causes of pancreatic cancer has been made …

[HTML][HTML] A predictive model based on the gut microbiota improves the diagnostic effect in patients with cholangiocarcinoma

T Zhang, S Zhang, C Jin, Z Lin, T Deng… - Frontiers in Cellular …, 2021 - frontiersin.org
Cholangiocarcinoma (CCA) is a malignant hepatic tumor with a poor prognosis, which
needs early diagnosis urgently. The gut microbiota has been shown to play a crucial role in …

[HTML][HTML] Circulating microbiota-based metagenomic signature for detection of hepatocellular carcinoma

EJ Cho, S Leem, SA Kim, J Yang, YB Lee, SS Kim… - Scientific reports, 2019 - nature.com
Circulating microbial dysbiosis is associated with chronic liver disease including
nonalcoholic steatohepatitis and alcoholic liver disease. In this study, we evaluated whether …

[HTML][HTML] A faecal microbiota signature with high specificity for pancreatic cancer

E Kartal, TSB Schmidt, E Molina-Montes… - Gut, 2022 - gut.bmj.com
Background Recent evidence suggests a role for the microbiome in pancreatic ductal
adenocarcinoma (PDAC) aetiology and progression. Objective To explore the faecal and …

[HTML][HTML] Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment

I Bartolini, M Risaliti, R Tucci, P Muiesan… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Liver cancer is a leading cause of death worldwide, and hepatocellular carcinoma (HCC) is
the most frequent primary liver tumour, followed by cholangiocarcinoma. Notably, secondary …

[HTML][HTML] Gut microbial profile in patients with pancreatic cancer

XY Wang, ZX Sun, EC Makale, ZK Sun… - Jundishapur Journal of …, 2022 - brieflands.com
Background: Pancreatic cancer is a lethal tumor with a poor prognosis. The connection
between pancreatic cancer and gut microbiota is less reported. Objectives: This study …

[HTML][HTML] Pancreatic cancer meets human microbiota: close encounters of the third kind

T Arsenijevic, R Nicolle, C Bouchart, N D'Haene… - Cancers, 2021 - mdpi.com
Simple Summary The microorganisms colonizing the epithelial surfaces of the human body,
called microbiota, have been shown to influence the initiation, progression and response to …